Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DARIUS A SCHNEIDER

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1679984520
CMS profile
2868054
Location
LA JOLLA, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$29,689.01

130 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

Page 2 of 3; records 51–100 of 130 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

DARIUS A SCHNEIDER

NPI 1679984520 · CMS profile ID 2868054

Allopathic & Osteopathic Physicians / Internal Medicine / Endocrinology, Diabetes & Metabolism

LA JOLLA, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 130 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1679984520?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
DARIUS A SCHNEIDER, NPI 1679984520, CMS profile ID 2868054. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 130 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1679984520?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). DARIUS A SCHNEIDER, NPI 1679984520, CMS profile ID 2868054. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 130 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1679984520?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
DARIUS A SCHNEIDER, NPI 1679984520, CMS profile ID 2868054, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 130 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1679984520?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

130 matching records · $29,689.01 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 130 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 130.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Abbott Laboratories $16.4807/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240953569 CMS
Ascensia Diabetes Care Us Inc. $14.1506/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225127704 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $22.4806/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223026646 CMS
SANOFI-AVENTIS U.S. LLC $10.7806/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233439564 CMS
Verity Pharmaceuticals Inc. $21.0506/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234196514 CMS
Amgen Inc. $26.1906/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228309601 CMS
Tandem Diabetes Care, Inc. $21.6206/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241303149 CMS
SANOFI-AVENTIS U.S. LLC $146.2806/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233439554 CMS
SANOFI-AVENTIS U.S. LLC $2,665.0006/17/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1233439556 CMS
Amgen Inc. $23.3006/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228309615 CMS
Mannkind Corporation $17.9206/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250882882 CMS
Ascensia Diabetes Care Us Inc. $31.9906/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225128537 CMS
Novo Nordisk Inc $6.9806/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1188492677 CMS
SANOFI-AVENTIS U.S. LLC $31.9306/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233439566 CMS
Ascensia Diabetes Care Us Inc. $32.8705/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225128539 CMS
Almatica Pharma LLC $28.6905/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1209936567 CMS
Amgen Inc. $28.3305/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228309581 CMS
SANOFI-AVENTIS U.S. LLC $6,662.5005/21/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1233439546 CMS
SANOFI-AVENTIS U.S. LLC $594.3005/21/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233439548 CMS
SANOFI-AVENTIS U.S. LLC $32.7205/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233439558 CMS
SANOFI-AVENTIS U.S. LLC $228.7505/21/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233439560 CMS
BETA BIONICS, INC. $19.6605/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1246810403 CMS
SANOFI-AVENTIS U.S. LLC $11.8905/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233439580 CMS
ABBVIE INC. $17.6905/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204114937 CMS
Abbott Laboratories $26.1805/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240933682 CMS
Insulet Corporation $34.7805/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1207144560 CMS
Amgen Inc. $28.6605/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228309579 CMS
SANOFI-AVENTIS U.S. LLC $17.2705/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233439536 CMS
Ascensia Diabetes Care Us Inc. $11.7004/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225127702 CMS
RECORDATI_RARE_DISEASES_INC. $26.4704/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1181723831 CMS
Amgen Inc. $18.4104/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228309613 CMS
Bayer Healthcare Pharmaceuticals Inc. $15.3704/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225776186 CMS
Lilly USA, LLC $27.7804/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186585012 CMS
CeQur Corporation $34.0204/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228227132 CMS
Amgen Inc. $15.8304/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228309611 CMS
Xeris Pharmaceuticals, Inc. $22.3504/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250153960 CMS
SANOFI-AVENTIS U.S. LLC $2,132.0003/27/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1233439530 CMS
TOLMAR, INC. $17.3903/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1237012092 CMS
SANOFI-AVENTIS U.S. LLC $5.7403/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233439518 CMS
Ascensia Diabetes Care Us Inc. $10.0203/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225128551 CMS
Amgen Inc. $14.5203/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227189866 CMS
Antares Pharma, Inc. $18.9003/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235896989 CMS
Bayer Healthcare Pharmaceuticals Inc. $24.0903/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225776183 CMS
Lilly USA, LLC $19.8803/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186576124 CMS
Novo Nordisk Inc $18.4503/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189043226 CMS
SANOFI-AVENTIS U.S. LLC $14.2303/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233439514 CMS
Ascensia Diabetes Care Us Inc. $10.1203/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225127700 CMS
Lilly USA, LLC $16.8203/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186622160 CMS
Amgen Inc. $28.2103/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228309603 CMS
Ascendis Pharma Endocrinology Inc $22.9703/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1237035373 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $481.60 8
PY2020 $609.14 24
PY2021 $1,095.08 63
PY2022 $6,908.57 70
PY2023 $8,455.73 103
PY2024 $7,223.54 156
PY2025 $29,689.01 130

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $15.94 1
PY2025 Principal investigator $109,222.58 2

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

3 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Eli Lilly and Company $94,005.00 06/03/2025 Non-covered Recipient Entity
DARIUS A SCHNEIDER MD APC ENDOTRIALS
A PHASE 3, RANDOMIZED, MULTICENTER, DOUBLE-BLIND STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF RETATRUTIDE ONCE WEEKLY COMPARED WITH PLACEBO IN ADULT PARTICIPANTS WITH TYPE 2 DIABETES, MODERATE OR SEVERE RENAL IMPAIRMENT WITH INADEQUATE GLYCEMIC CONTROL ON BASAL INSULIN WITH OR WITHOUT METFORMIN AND/OR SGLT2 INHIBITOR No dispute reported 06/30/2026 1187883834
Recipient Eli Lilly and Company $15.94 04/21/2025 Covered Recipient Physician A PHASE 3, RANDOMIZED, MULTICENTER, DOUBLE-BLIND STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF RETATRUTIDE ONCE WEEKLY COMPARED WITH PLACEBO IN ADULT PARTICIPANTS WITH TYPE 2 DIABETES, MODERATE OR SEVERE RENAL IMPAIRMENT WITH INADEQUATE GLYCEMIC CONTROL ON BASAL INSULIN WITH OR WITHOUT METFORMIN AND/OR SGLT2 INHIBITOR No dispute reported 06/30/2026 1187871133
Principal investigator 1 Eli Lilly and Company $15,217.58 01/31/2025 Non-covered Recipient Entity
NEUROLOGY CLINIC PC
A PHASE 3, RANDOMIZED, MULTICENTER, DOUBLE-BLIND STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF RETATRUTIDE ONCE WEEKLY COMPARED WITH PLACEBO IN ADULT PARTICIPANTS WITH TYPE 2 DIABETES, MODERATE OR SEVERE RENAL IMPAIRMENT WITH INADEQUATE GLYCEMIC CONTROL ON BASAL INSULIN WITH OR WITHOUT METFORMIN AND/OR SGLT2 INHIBITOR No dispute reported 06/30/2026 1187884898